eanNews Editor, Benedetta Bodini, highlights some recent developments on the EAN's popular news platform
Category
Featured Slider
-
-
Welcome to the April 2026 edition of the President’s Corner, our article series in which the EAN President, Elena Moro, answers your questions!
-
Paper of the MonthEAN NewsResearchFeatured Slider
Research Paper of the Month: Efficacy and safety of minocycline in patients with acute ischaemic stroke (EMPHASIS)
April 8, 2026Results of the EMPHASIS study, evaluating the efficacy and safety of minocycline in addition to routine treatment in patients with acute ischaemic stroke. -
Executive PageBrain HealthEAN NewsFeatured Slider
Executive Page: Multiple Opportunities to Serve & Support EAN & Neurology
March 12, 2026EAN President-Elect, Kailash Bhatia, looks ahead to the forthcoming EAN Board elections and activities for Brain Awareness Week. -
Brain HealthPresident's CornerEAN NewsFeatured Slider
President’s Corner – March 2026
March 10, 2026Welcome to the March 2026 edition of the President’s Corner, our article series in which the EAN President, Elena Moro, answers your questions! -
Paper of the MonthEAN NewsResearchFeatured Slider
Research Paper of the Month: Coffee and Tea Intake, Dementia Risk, and Cognitive Function
March 2, 2026Large prospective analysis examining association of long-term coffee and tea intake with incident dementia, and with subjective and objective cognitive outcomes. -
Executive PageEAN NewsEducation cornerEducationFeatured Slider
Executive Page: Building an Academic Path for Neurologists in Europe
February 11, 2026EAN Education Committee Chair, Prof. Nathalie Nasr, gives an update on the academic path provided by the EAN’s educational activities. -
Welcome to the February 2026 edition of the President’s Corner, our article series in which the EAN President, Elena Moro, answers your questions!
-
Paper of the MonthEAN NewsResearchFeatured Slider
Research Paper of the Month: Fremanezumab in Children and Adolescents with Episodic Migraine
February 11, 2026Results of a multicentre, placebo-controlled trial evaluating the efficacy and safety of fremanezumab in children and adolescents aged 6–17 years with episodic migraine. -
Executive PageEAN NewsEAN Congress newsFeatured Slider
Executive Page: Get Ready to Join us for our 12th Congress in Geneva!
January 12, 2026EAN Programme Committee Chair, Irena Rektorova, provides a preview of the EAN Congress 2026, looking at programme highlights, new features, and how you can get involved! -
Welcome to the January 2026 edition of the President’s Corner, our article series in which the EAN President, Elena Moro, answers your questions!
-
Paper of the MonthEAN NewsResearchFeatured Slider
Research Paper of the Month: Medical Management and Revascularization for Asymptomatic Carotid Stenosis
January 12, 2026Results of the CREST-2 study, comparing carotid artery stenting or carotid endarterectomy plus intensive medical therapy with intensive medical therapy alone in patients aged 35+ with asymptomatic high-grade carotid artery stenosis. -
Executive PageEAN NewsFeatured Slider
Executive Page: EAN President on a Busy 2025 and Exciting Prospects for 2026
December 12, 2025EAN President Elena Moro looks back at some of the major highlights of 2025 and forward to some projects and events lined up for 2026. -
Welcome to the December 2025 edition of the President’s Corner, our article series in which the EAN President, Elena Moro, answers your questions!
-
Paper of the MonthEAN NewsResearchFeatured Slider
Research Paper of the Month: Physical activity as a modifiable risk factor in preclinical Alzheimer’s disease
December 12, 2025This study assessed cognitively unimpaired older adults using pedometer-measured physical activity, longitudinal Aβ and tau PET imaging, and annual cognitive evaluations over 14 years.
Newer Posts
